Use of White Granulated Sugar on Wounds

A Randomised Controlled Trial to Investigate the Clinical and Cost-effectiveness of White Granulated Sugar Dressing Compared With Standard Treatment in the Management of Exudating Wounds With Parallel Economic Evaluation

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01716273

Enrollment

108

Registered

2012-10-29

Start date

2011-06-30

Completion date

2014-10-31

Last updated

2012-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infected Wounds

Brief summary

How effective is sugar in reducing the debriding of sloughy, necrotic or infected exudating wounds compared with standard treatment?

Detailed description

Patients for whom all the following apply: Have an exudating wound sizes 5cm2 and 40cm2 A minimum of 25% slough, infected and necrotic tissue No dry necrotic eschar present Ankle Brachial Pressure Index of greater than 0.6 Are over 18 years Independently and willingly consent

Interventions

OTHERGranulated Sugar

30 grams of granulated sugar is used to cover the wound area and this is held in place using a dry dressing pad , bandage and tape.

OTHERDebridement Dressing

1 Aquacel or Sorbsan dressing will be put over the wound, and held in place with a dry dressing pad, bandage and tape.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Exudating wound sizes 5cm2 and 40cm2 * A minimum of 25% slough, infected and necrotic tissue * No dry necrotic eschar * Ankle Brachial Pressure Index of greater than 0.6 * Age over 18 years * Able to independently and willingly consent

Exclusion criteria

* Participants in a trial evaluating other therapies for their wound * Have previously been in this trial * Women who are pregnant * Participants not able to tolerate daily dressing change

Design outcomes

Primary

Measure	Time frame	Description
Time to debridement of wound	4 weeks	wounds will be photographed at entry into the study there after weekly till end of study at 4 weeks

Secondary

Measure	Time frame	Description
Reduction in wound surface area	4 weeks	Wound measurements will be taken at entry into the study then weekly until end of 4 weeks

Other

Measure	Time frame	Description
Quality of life	4 weeks	Participants will be given a QOL questionnaire to complete before commencing the treatment and at the end of the 4 weeks

Countries

United Kingdom

Contacts

Primary ContactMoses Murandu, PhD student

mosesmurandu@wlv.ac.uk07743025072

Backup ContactMalcolm Simms, MBBSFRCS

malcolm.simms@uhb.nhs.uk07768147025

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026